StockData
Stryker Corp logo

Stryker Corp

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)

Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –

Stryker Inari Medical by Quarter

Inari Medical — FDA MAUDE Adverse Event Reports (reports)

QuarterlyAnnualMonthly

Stryker Inari Medical: 23 in Q3 2026, up 4.5% from a year earlier.

Latest, Q3 2026
23
Period ended Sep 30, 2026
Change on a year earlier
+4.5%
22 in Q3 2025
History
35 quarters
Since Q1 2018
Sources
1
U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical

Where the Q3 2026 figure comes from

Source: U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedInari Medical — FDA MAUDE Adverse Event Reports (reports)Year on yearSource
Q3 2026Sep 30, 202623+4.5%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q2 2026Jun 30, 202624+33.3%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q1 2026Mar 31, 202629+26.1%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q4 2025Dec 31, 202536+80.0%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q3 2025Sep 30, 202522+57.1%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q2 2025Jun 30, 202518+20.0%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q1 2025Mar 31, 202523+35.3%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q4 2024Dec 31, 202420+33.3%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q3 2024Sep 30, 202414+133.3%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q2 2024Jun 30, 202415+114.3%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q1 2024Mar 31, 202417+183.3%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q4 2023Dec 31, 202315+275.0%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q3 2023Sep 30, 20236+20.0%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q2 2023Jun 30, 20237+16.7%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q1 2023Mar 31, 20236+20.0%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q4 2022Dec 31, 20224-42.9%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗

Cite this data

StockData. (2026). Stryker Inari Medical, quarterly Q1 2018–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/nari-fda-maude

See every metric in the Stryker KPI table. Data updated Nov 2, 2026.